Trial Details
ACTIVE_NOT_RECRUITINGBasic Information
| Clinical ID | c1160 |
|---|---|
| Identifier | NCT05486104 |
| Trial Title | Phase II Study of Hemay005 in Patients With Active Ulcerative Colitis |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Moderate to Severe Ulcerative Colitis |
| Interventions | DRUG: Hemay005 tablets|DRUG: Hemay005 placebo tablets |
Participant Information
| Sponsor | Ganzhou Hemay Pharmaceutical Co., Ltd |
|---|---|
| City | Hefei |
| Country/Region | China |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE2 |
Time Information
| Start Date | 2022-11-08 00:00:00.000000 |
|---|---|
| Primary Completion Date | 2025-12-30 00:00:00.000000 |
| Completion Date | 2025-12-30 00:00:00.000000 |